Recombinant GAD protein for Preclinical Research

Diamyd Medical offers instant and continuous delivery of highly purified (>99%) GAD65, which can be used for mechanistic studies and therapy development in preclinical research. When your application is approved for testing in clinical trials, Diamyd Medical can supply investigational GMP GAD65 fomulated in alum according to applicable regulations.

Quality Assurance

Full-length recombinant human GAD65 is supplied in 2 forms for scientific preclinical research use only. Final product for preclinical research is requalified by SDS-PAGE, Western blot, IEF and biological activity.

Protein Sequence and Functional Information

The UniProt Consortium provides protein sequence and functional information on human GAD65 (Glutamate Decarboxylase2).

  UniProtKB - Q05329 (DCE2HUMAN)

Product Data Sheets

  rhGAD65
Pure concentrated protein in process buffer
  T-cell GAD65
Biologically compatible RPMI buffer with 1mg/ml HSA

Sales Inquiry

TRAINING IMMUNE CELLS FOR T1D THERAPY
    Redirection of human autoreactive T-cells
    Modulating and priming DCs for redirection of cytotoxic T-cells
CHARACTERISATION OF STIMULATED IMMUNE CELLS
    T-cell cytokine secretion by ELISPOT3 or Luminex
    Cell surface characterisation by FACS analysis
    Proliferation assays by CFSE staining
TCR AND MHC BINDING ANALYSIS
    T-cell recognition of post-translational modifications of GAD65
    Control for TCR peptide stimulation and TCR binding analysis
CHARACTERISATION OF GAD AUTOANTIBODIES
    GADA assays using biotinylated GAD65
    Plasmon enhanced GADA chip
    Isotype analysis of GADA
DIAGNOSIS OF NEUROLOGICAL DISEASES
    GAD65 IgG-Ab characterisation in Stiff Person Syndrome

 Quotation Form

rhGAD65 and T-cell GAD is offered to academia and industry for preclinical research purposes only and may not be used in humans.

Products to quote *
Art No Product Quantity
10-65702-01
10-65702-20-01
 
* = required field.
Purchase order required, 30 day payment terms.